Ben J. Boyd
Title
Cited by
Cited by
Year
Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems
BJ Boyd, DV Whittaker, SM Khoo, G Davey
International journal of pharmaceutics 309 (1-2), 218-226, 2006
3032006
Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure
YD Dong, I Larson, T Hanley, BJ Boyd
Langmuir 22 (23), 9512-9518, 2006
2892006
Stimuli responsive liquid crystals provide ‘on-demand’drug delivery in vitro and in vivo
WK Fong, T Hanley, BJ Boyd
Journal of Controlled Release 135 (3), 218-226, 2009
2752009
Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation
CJH Porter, AM Kaukonen, BJ Boyd, GA Edwards, WN Charman
Pharmaceutical research 21 (8), 1405-1412, 2004
2532004
Characterisation of drug release from cubosomes using the pressure ultrafiltration method
BJ Boyd
International journal of pharmaceutics 260 (2), 239-247, 2003
2472003
Advances in drug delivery and medical imaging using colloidal lyotropic liquid crystalline dispersions
X Mulet, BJ Boyd, CJ Drummond
Journal of colloid and interface science 393, 1-20, 2013
2352013
Minimum information reporting in bio–nano experimental literature
M Faria, M Björnmalm, KJ Thurecht, SJ Kent, RG Parton, M Kavallaris, ...
Nature nanotechnology 13 (9), 777-785, 2018
2042018
Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine
CJH Porter, AM Kaukonen, A Taillardat-Bertschinger, BJ Boyd, ...
Journal of pharmaceutical sciences 93 (5), 1110-1121, 2004
2012004
Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations
AM Kaukonen, BJ Boyd, CJH Porter, WN Charman
Pharmaceutical research 21 (2), 245-253, 2004
1962004
Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected …
GA Kossena, BJ Boyd, CJH Porter, WN Charman
Journal of pharmaceutical sciences 92 (3), 634-648, 2003
1922003
The Impact of Molecular Weight and PEG Chain Length on the Systemic Pharmacokinetics of PEGylated Poly l-Lysine Dendrimers
LM Kaminskas, BJ Boyd, P Karellas, GY Krippner, R Lessene, B Kelly, ...
Molecular pharmaceutics 5 (3), 449-463, 2008
1782008
How chain length, headgroup polymerization, and anomeric configuration govern the thermotropic and lyotropic liquid crystalline phase behavior and the air− water interfacial …
BJ Boyd, CJ Drummond, I Krodkiewska, F Grieser
Langmuir 16 (19), 7359-7367, 2000
1772000
Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs
KWY Lee, TH Nguyen, T Hanley, BJ Boyd
International journal of pharmaceutics 365 (1-2), 190-199, 2009
1752009
Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration
TH Nguyen, T Hanley, CJH Porter, BJ Boyd
Journal of controlled release 153 (2), 180-186, 2011
1702011
Evaluating the link between self-assembled mesophase structure and drug release
S Phan, WK Fong, N Kirby, T Hanley, BJ Boyd
International journal of pharmaceutics 421 (1), 176-182, 2011
1642011
A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats
BJ Boyd, SM Khoo, DV Whittaker, G Davey, CJH Porter
International journal of pharmaceutics 340 (1-2), 52-60, 2007
1602007
Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties
LM Kaminskas, BJ Boyd, CJH Porter
Nanomedicine 6 (6), 1063-1084, 2011
1552011
Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38
V Bala, S Rao, BJ Boyd, CA Prestidge
Journal of controlled release 172 (1), 48-61, 2013
1512013
Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines
SB Rizwan, D Assmus, A Boehnke, T Hanley, BJ Boyd, T Rades, S Hook
European Journal of Pharmaceutics and Biopharmaceutics 79 (1), 15-22, 2011
1442011
Hexosomes formed from glycerate surfactants—formulation as a colloidal carrier for irinotecan
BJ Boyd, DV Whittaker, SM Khoo, G Davey
International journal of pharmaceutics 318 (1-2), 154-162, 2006
1432006
The system can't perform the operation now. Try again later.
Articles 1–20